Skip to main content

Chronic Inflammatory Demyelinating Polyneuropathy Market Research on Company Profiles with Sales and Revenue

Global Chronic Inflammatory Demyelinating Polyneuropathy Market size is set to the cross the mark of USD 3907.17 million with a Growing CAGR of CAGR of 6.2% during the forecast period, 2015-2023.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Analysis By Treatment (Intravenous Immunoglobulin, Corticosteroids, Plasmapheresis (Plasma Exchange), Physiotherapy, Others), Diagnosis (Electrodiagnostic Testing, Nerve Conduction, EMG, Spinal Fluid Analysis, Others), By Route of Administration (Intravenous, Oral, Others), By End User (Hospitals, Specialty Neurological Clinics, Research & Academic Laboratories, Others), Industry Size, Growth, Technology, Share, Trends and Top Regions Forecast till 2023.
The increasing incidence of CIDP is a major concern in the medical sector, especially in developed countries. Several public and private organizations launched initiatives for R&D activities that produced positive results in the area of ​​CIDP.
The prevalence of autoimmune diseases has increased dramatically, paving the way for the growth of the global market for chronic inflammatory demyelinating polyneuropathy (CIDP). Remarkable results have been achieved through rigorous research and development efforts and clinical trials. Several new drugs are introduced following recent FDA approvals, which also spur growth of the global chronic inflammatory demyelinating polyneuropathy market. Other factors supporting the market growth comprise growing awareness of the disease and government initiatives on the same.
Some of the well-established market players in the global CIDP market includes
Pfizer Inc
Bio Products Laboratory Ltd.
Mitsubishi Tanabe Pharma Corporation
Baxter
Kedrion S.p.A
Octapharma
Shire
Momenta Pharmaceuticals
Grifols
CSL Behring
Teijin Pharma Limited
Industry Segmentation
The global market is diversified on the basis of the route of administration, treatment and diagnosis, and end-user.
The global chronic inflammatory demyelinating polyneuropathy market is divided into treatment and diagnoses. The treatment segment with the largest market share is further segmented into corticosteroids, plasma fermentation, intravenous immunoglobulin (IVIg), The global market is diversified on the basis of the route of administration, treatment, and diagnosis, and end-user.
The global chronic inflammatory demyelinating polyneuropathy market is divided into treatment and diagnoses. The treatment segment with the largest market share is further segmented into corticosteroids, plasma fermentation, physiotherapy, intravenous immunoglobulin (IVIg), plasmapheresis (plasma exchange), and others. The treatment segment also saw CAGR growth by 6.32% in the period due to growing demand for effective CIDP treatments. Of the different sub-segments, the IVIG sub-segment has achieved leadership status due to its preference for IVIg as a first-line treatment method for CIDP.
On the basis of the route of administration, the chronic inflammatory demyelinating polyneuropathy market is classified into intravenously and orally. Due to the strong preference for IVIG treatment that penetrates directly into the blood to respond more rapidly, the intravenous route segment is expected to gain the largest market share and highest annual growth over the forecast period. The intravenous solutions segment represents 85% of total market share, followed by oral and other treatments.
Based on end-users of the chronic inflammatory demyelination market for polyneuropathy is subdivided into specialized neurological clinics, research laboratories, hospitals, and academics, and others. Hospitals have gained a 49% share of the global market due to their wide presence and preference for hospitals. However, patients are progressively seeing the value of specialist clinics where they can better know their disease. As a result, the segment of specialized neurological clinics had the fastest CAGR growth of 6.49% during the period considered.
The main geographies covered in MRFR’s report include the Americas, Europe, Asia Pacific, and the Middle East & Africa. The global chronic inflammatory demyelinating polyneuropathy market has witnessed the highest presence in the Americas market. Possessing a share of 52% of the global market
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Rising prevalence of autoimmune diseases
5.2.2 Increasing research and development related to plasma-derived medicines
5.2.3 Increasing awareness about Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3 Restraints
5.3.1 Side-effects associated with the Intravenous Immunoglobulin (IVIG) treatment
5.3.2 High cost of the IVIG treatment
5.4 Opportunity
5.4.1 Advancements in the treatment
5.5 Clinical Trials Data
Ask for any Query Feel Free To contact at: https://www.marketresearchfuture.com/enquiry/6947
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Dupuytren's contracture Market Size, Growth Analysis By Types, Treatment on Top Key Players

Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle finger. The exact causes of Dupuytren's contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc. The  global Dupuytren’s contracture market is expected to reach USD 5.5 billion ...
Post a Comment
Read more

Acoustic Insulation Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

  The Global Acoustic Insulation Market share is expected to grow at more than 4.6% CAGR from 2019 to 2028. It is expected to reach above USD 19.6 billion by 2028. Acoustic Solutions as we know is an important ingredient for industrial and residential production. The Acoustic Insulation market for Acoustic Solutions has also seen a significant growth and is expected to see growing in coming years. There are few market drivers and restraints behind this growth. Technological changes in the automobile industry are leading complete makeover of industry. This make over will be gradual in its course. Development of Lithium-Ion battery, increasing preference of the consumer as well as nudging by government for the consumption of clean energy is leading to significant overhaul of the industry. Various regional markets have committed to reduce and ultimately stop the consumption of fossil fuel in coming decades. To tackle the issue of pollution and safety, India which is the fourth largest...
Post a Comment
Read more

Medical Billing Outsourcing Market Technological Scope, Future Trends and Growth Analysis by Types

Medical Billing Outsourcing Market Research Report: Information by Component (In House & Outsourced), Service (Front End Service, Middle End Service, & Back End Service), End User (Hospitals, Physician’s Office, & Others) — Global Forecast till 2023 The report presents a detailed analysis of  Medical Billing Outsourcing Market  by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. R1...
Post a Comment
Read more